Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges

被引:44
作者
Solomon, D. H. [1 ,2 ]
Mercer, E. [2 ]
Woo, S. B. [3 ,4 ]
Avorn, J. [1 ]
Schneeweiss, S. [1 ]
Treister, N. [3 ,4 ]
机构
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Oral Med, Boston, MA 02115 USA
关键词
Bisphosphonate; Epidemiology; Osteonecrosis of the jaw; Osteoporosis; ORAL BISPHOSPHONATES; SURGERY; PREVALENCE;
D O I
10.1007/s00198-012-2042-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bisphosphonate-related osteonecrosis of the jaw (BONJ) is an adverse effect of bisphosphonate use with a poorly described epidemiology in osteoporosis patients. We examined the literature and two new cohorts for BONJ. The literature suggests an incidence rate of 0.028 % to 4.3 %. Our cohort studies found an incidence of 0.02 % (95 % CI 0.004 %-0.11 %). We examined the epidemiology of BONJ associated with osteoporosis dosing of bisphosphonates. First, we systematically searched the literature about osteoporosis BONJ. Identified studies were abstracted by two authors. Second, we attempted to estimate the relative risk of BONJ among bisphosphonate users with osteoporosis. Two different large insurance databases, one from 2005-2007 and another from 2007-2010, combined with medical record review, were searched. The older dataset did not include the International Classification of Diagnoses (ICD) diagnosis code for osteonecrosis of the jaw (ONJ; ICD 733.45). Incidence rates and relative risks were estimated using Cox regression. The literature review produced nine studies of varying quality. The incidence rates for BONJ among osteoporosis patients varied from 0.028 % to 4.3 %. Two prior studies estimated the relative risk of ONJ related to bisphosphonates and found odds ratios of 7.2 and 9.2. Our attempts to estimate the incidence rate of BONJ encompassed 41,957 in the dataset from 2005-2007 and 466,645 in a separate dataset from 2007-2010. From the older dataset, we found 51 potential cases of BONJ using a broad definition of possible ONJ. One case was confirmed by a dentist for a prevalence of 0.02 % (95 % CI 0.004 %-0.11 %) among bisphosphonate users. From the newer dataset, we found 13 possible cases, but none could be confirmed. Most subjects with the ONJ diagnosis code appeared to have had an osteoporosis-related fracture and not ONJ. The literature suggests a broad range of possible values for the prevalence of BONJ; our estimate fell within the range from prior literature.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 50 条
  • [31] Factors associated with osteonecrosis of the jaw among bisphosphonate users
    Hess, Lisa M.
    Jeter, Joanne M.
    Benham-Hutchins, Marge
    Alberts, David S.
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (06) : 475 - +
  • [32] Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw A review
    Almazrooa, Soulafa A.
    Woo, Sook-Bin
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2009, 140 (07) : 864 - 875
  • [33] Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients
    Pozzi, Samantha
    Marcheselli, Raffaella
    Sacchi, Stefano
    Baldini, Luca
    Angrilli, Francesco
    Pennese, Elsa
    Quarta, Giovanni
    Stelitano, Caterina
    Caparotti, Giuseppe
    Luminari, Stefano
    Musto, Pellegrino
    Natale, Donato
    Broglia, Chiara
    Cuoghi, Angela
    Dini, Daniele
    Di Tonnoi, Paolo
    Leonardi, Giovanna
    Pianezze, Graziano
    Pitini, Vincenzo
    Polimeno, Giuseppe
    Ponchio, Luisa
    Masini, Luciano
    Musso, Maurizio
    Spriano, Mauro
    Pollastri, Giuseppe
    LEUKEMIA & LYMPHOMA, 2007, 48 (01) : 56 - 64
  • [34] Insight into bisphosphonate-associated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management
    Wimalawansa, Sunil J.
    EXPERT OPINION ON DRUG SAFETY, 2008, 7 (04) : 491 - 512
  • [35] Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis
    Walter, Christian
    Groetz, Knut A.
    Kunkel, Martin
    Al-Nawas, Bilal
    SUPPORTIVE CARE IN CANCER, 2007, 15 (02) : 197 - 202
  • [36] Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis
    Christian Walter
    Knut A. Grötz
    Martin Kunkel
    Bilal Al-Nawas
    Supportive Care in Cancer, 2007, 15 : 197 - 202
  • [37] Stress response in periodontal ligament stem cells may contribute to bisphosphonate-associated osteonecrosis of the jaw: A gene expression array analysis
    Shi, Yueqi
    Li, Mengyu
    Yu, Yejia
    Zhou, Yuqiong
    Zhang, Wenjie
    Hua, Hongfei
    Wang, Shaoyi
    MOLECULAR MEDICINE REPORTS, 2020, 22 (03) : 2043 - 2051
  • [38] Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature
    Jan Rustemeyer
    Andreas Bremerich
    Clinical Oral Investigations, 2010, 14 : 59 - 64
  • [40] Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature
    Rustemeyer, Jan
    Bremerich, Andreas
    CLINICAL ORAL INVESTIGATIONS, 2010, 14 (01) : 59 - 64